This study is in progress, not accepting new patients
A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)
Summary
- Eligibility
- for males ages 4-9 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Stanley F. Nelson, MD
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Stanley F. Nelson, MD
Dr. Stanley Nelson holds the Dr. Allen and Charlotte Ginsburg Endowed Chair in Translational Genomics.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Edgewise Therapeutics, Inc.
- Links
- Sponsor Website Sign up for this study
- ID
- NCT05540860
- Phase
- Phase 2 Duchenne Muscular Dystrophy Research Study
- Study Type
- Interventional
- Participants
- About 76 people participating
- Last Updated